Expanding from its core sleep apnoea franchise, Resmed has paid $500 million to treat the common restless leg syndrome.

Venter led the private effort to sequence the human genome and created the first synthetic bacterial cell while launching ...

Chiesi Group (“Chiesi”), an international research-focused biopharmaceutical group and certified B Corp, and KalVista ...

Labcorp raised its full-year profit and revenue forecast on Thursday after posting quarterly results above expectations as ...

It has been known for years by insiders as the “hidden gem” of North Carolina’s life sciences ecosystem. And now, after four ...

Thermo Fisher Scientific is shedding its microbiology business to private equity firm Astorg nearly a year after initial ...

Eli Lilly announced Monday it will acquire Boston-based Kelonia Therapeutics with an initial payment of $3.25 billion, as the pharmaceuticals giant looks to bolster its position in the global cancer ...

Amazon will invest as much as $25 billion in the AI company, which will secure up to 5 gigawatts in badly needed computing power in the pact. Tim Cook to Step Down as Apple Names New CEO John Ternus, ...

Eli Lilly struck a deal to acquire Kelonia Therapeutics for $3.25 billion, the companies said Monday. The deal price could reach as much as $7 billion if Kelonia reaches certain clinical, regulatory ...

Though American has rejected a deal, lawmakers ask both carriers to share how it could affect routes and fares. Honeywell to Sell Productivity Unit for $1.4 Billion Brady Corp. agreed to acquire ...

Biogen said on Monday it had agreed to pay up to $850 million to acquire exclusive rights in Greater China to an ​experimental immune disease treatment from Chinese biotech ‌firm TJ Biopharma, giving ...